Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Elevated INR in liver disease not protective against clots

NEW YORK (Reuters Health) - Although patients with liver disease often have an increased international normalized ratio (INR), their coagulopathy does not protect against venous thromboembolism (VTE), new research suggests. The findings stem from a study of 190 hospitalized patients with chronic liver...

Reuters Health • The Doctor's Channel Daily Newscast

Leukemia relapse risk drops with 2-unit umbilical cord blood transfusion

NEW YORK (Reuters Health) – Transfusion of two rather than one unit of partially HLA-matched umbilical cord blood (UCB) appears to reduce the risk of relapse in leukemia patients in first or second complete remission, new research shows. “Our analysis showed that patients in first or second remission...

Reuters Health • The Doctor's Channel Daily Newscast

Erythropoiesis-stimulating agents: concern over patterns of use and risks

NEW YORK (Reuters Health) - Use of erythropoiesis-stimulating agents in US cancer patients undergoing chemotherapy has increased 10-fold since their introduction, yet there's been no associated decline in the rate of blood transfusions, according to a study published today. "It is also clear that when...